Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
December 5, 2022
Human lymphoid tissue sampling for vaccinology
Karolina M Kwiatkowska, Catherine G Mkindi, Carolyn M Nielsen
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Dysfunctional memory B cell responses to the protective repeat region of the <i>Plasmodium</i> circumsporozoite protein are associated with waning humoral immunity
Courtney E McDougal, Catherine G Mkindi, Lauren B Rodda, et al.
Frontiers in Immunology
|
February 1, 2024
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
Jordan R Barrett, Sarah E Silk, Catherine G Mkindi, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
December 5, 2022
Human lymphoid tissue sampling for vaccinology
Karolina M Kwiatkowska, Catherine G Mkindi, Carolyn M Nielsen
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Dysfunctional memory B cell responses to the protective repeat region of the <i>Plasmodium</i> circumsporozoite protein are associated with waning humoral immunity
Courtney E McDougal, Catherine G Mkindi, Lauren B Rodda, et al.
Frontiers in Immunology
|
February 1, 2024
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
Jordan R Barrett, Sarah E Silk, Catherine G Mkindi, et al.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
Page
of 1